Skip to main content

UBS Group AG

Position in ALXO — Alx Oncology Holdings Inc

CIK 1610520 ZURICH, V8

Position in ALXO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,834,080
+$855,511 QoQ
Shares Held
914,754
+5.6% QoQ
Ownership
0.680%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 68 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALXO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. ALXO ranks #212 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALXO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,834,080 914,754
2025-12-31 $978,569 865,991
2025-09-30 $315,802 172,570
2025-06-30 $119,802 288,685
2025-03-31 $159,794 256,493
2024-12-31 $681,453 408,056
2024-09-30 $53,215 29,240
2024-06-30 $93,180 15,453
2024-03-31 $324,175 29,074
2023-12-31 $461,410 30,988
2023-09-30 $53,730 11,194
2023-06-30 $92,837 12,362
2023-03-31 $45,394 10,043
2022-12-31 $81,617 7,242
2022-03-31 $1,454,616 86,072
2021-12-31 $2,015,717 93,798
2021-09-30 $536,665 7,266
2021-06-30 $259,073 4,738
2021-03-31 $1,397,225 18,948
2020-12-31 $4,310 50